Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services
Select solutions (1)
Active Filters (1)
Clear All
25 - 36 of 158 Results
Sort by:
Best Match
Protocol/SOP
IVISbrite lentiviral particles transduction protocol (SOP)
Transduction protocol for using Revvity's IVISbrite lentiviral particles.
Flyer
Best practices for designing an effective in vivo fluorescence imaging study
Best practices for designing an effective in vivo fluorescence imaging study.
Case Study
Assessment of MYC-driven progression of small cell lung cancer
Researchers at Huntsman Cancer Center use GEMM and the Quantum microCT system for evaluating small cell lung cancer.
Literature - Publication Review
Deciphering the properties of neuronal nicotinic acetylcholine receptors using radiolabeled α-Bungarotoxin
Deciphering the Properties of Nicotinic Acetylcholine Receptors Using 125I-α-Bungarotoxin
Application Note
Optimizing 384-well qPCR plate preparation while decreasing costs
How to decrease 384-well qPCR plate preparation time and costs using FlexDrop iQ Non-Contact Dispenser. qPCR solutions compared by the Centre for Cancer Biology.
Brochure
Drug discovery and development tailor made
Learn more about our Custom Discovery Reagent and Assay Services to further your research, backed by 30+ years of experience.
Flyer
Radiochemical Custom Synthesis and Labeling
Radiochemical custom synthesis and labeling services from Revvity
Technical Note
Article
cst-research-spotlight-qa-alves-opioids-bone-homogenization
Method development for toxicological analysis of synthetic opioids from bone.
Whitepaper
Dual NIR imaging of β-Amyloid plaques and Tau tangles provides potential insights into Alzheimer’s disease
The use of Dual NIR Imaging of β-Amyloid Plaques and Tau Tangles to provide Potential Insights into Alzheimer’s Disease
Application Note
Effectiveness of CRISPR-Cas9 using pools of Dharmacon™ Edit-R™ synthetic crRNAs in high-content analysis screening experiments
Find out about the effectiveness of CRISPR-Cas9 using pools of Dharmacon™ Edit-R™ synthetic crRNAs in HCA screening experiments.
Application Note
Pooled phenotypic CRISPR screening enables the identification of synergistic drug combinations for cancer therapy
This application note demonstrates how a pooled phenotypic CRISPR screening can be used to identify synergistic drug combinations for cancer therapy
Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.